Results 11 to 20 of about 19,359,542 (209)

Platelet role in the prediction of MIS-C severity

Frontiers in Pediatrics, 2023
IntroductionMultisystem inflammatory syndrome in children (MIS-C) has been reported as one of the cytokine storm syndromes associated with COVID-19.
Ausra Snipaitiene, Ausra Snipaitiene, Aurelija Sirataviciene, Aurelija Sirataviciene, Leila Varoneckaite, Leila Varoneckaite, Rima Sileikiene, Rima Sileikiene, Lina Jankauskaite, Lina Jankauskaite, Lina Jankauskaite   +10 more
doaj   +3 more sources

An epidemiological study of multisystem inflammatory syndrome in children (MIS-C) and young adults among COVID-19-positive patients – data from National Inpatient Sample database [PDF]

Rheumatology
During the pandemic of COVID-19, a novel atypical set of clinical findings was seen among several children with recent or current exposure to the virus. It was termed the “multisystem inflammatory syndrome in children” (MIS-C).
Shruti Aggarwal, Jasninder Singh Dhaliwal, Nomesh Kumar, Hemamalini Sakthivel, Raheel Ahmed, Renuka Verma, Kamleshun Ramphul   +6 more
doaj   +2 more sources

Treatment of MIS-C in Children and Adolescents [PDF]

Current Pediatrics Reports, 2022
Abstract Purpose of Review Different treatment approaches have been described for the management of COVID-19-related multisystem inflammatory syndrome in children (MIS-C), the pathogenesis of which has not yet been fully elucidated.
Sanaa Mahmoud, Mostafa El-Kalliny, Alyaa A. Kotby, Mona El-Ganzoury, Eman Fouda, Hanan Ibrahim   +5 more
openaire   +2 more sources

MIS-C: Diagnosis, Management, and Outcomes. [PDF]

Open Forum Infect Dis
Abstract Multisystem inflammatory syndrome in children (MIS-C) is an emergent postinfectious hyperinflammatory disorder predominantly affecting the pediatric population following COVID-19 infection. Clinically, it is characterized by persistent fever, shock, multiorgan involvement, and potentially severe cardiovascular involvement ...
El Rassi C, El Darzi R, Abou Mansour M, Arabi M.   +3 more
europepmc   +3 more sources

Immunomodulatory Therapy for MIS-C

Pediatrics, 2023
CONTEXT Studies comparing initial therapy for multisystem inflammatory syndrome in children (MIS-C) provided conflicting results. OBJECTIVE To compare outcomes in MIS-C patients treated with intravenous immunoglobulin (IVIG), glucocorticoids, or the
Ouldali, Naïm, Son, Mary Beth F., Mcardle, Andrew, Vito, Ortensia, Vaugon, Esther, Belot, Alexandre, Leblanc, Claire, Murray, Nancy, Patel, Manish, Levin, Michael, Randolph, Adrienne, Angoulvant, François   +11 more
openaire   +4 more sources

Mistaken MIS-C: A Case Series of Bacterial Enteritis Mimicking MIS-C

Pediatric Infectious Disease Journal, 2021
Multisystem inflammatory syndrome in children following severe acute respiratory syndrome coronavirus 2 infection is characterized by fever, elevated inflammatory markers, and multisystem organ involvement. Presentations are variable but often include gastrointestinal symptoms.
Dworsky, Zephyr D, Roberts, Jordan E, Son, Mary Beth F, Tremoulet, Adriana H, Newburger, Jane W, Burns, Jane C   +5 more
openaire   +5 more sources

The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)—Data from POLISH MIS-C Registry [PDF]

Children, 2022
Background: Multisystem inflammatory syndrome (MIS-C) is a condition related to COVID-19. It’s most significant feature is cardiac involvement. Methods: We have analyzed data from 42 hospitals in the Polish MIS-C Registry. To compare the effect of GCS on fever, we formed two groups: the first treated with IVIG and the second treated with IVIG+GCS ...
Ewelina Gowin, Kacper Toczyłowski, Artur Sulik, Jacek Wysocki, Danuta Januszkiewicz-Lewandowska   +4 more
openaire   +4 more sources

Case Report: Anterior Scleritis Presenting as a Primary Ocular Manifestation in Multisystem Inflammatory Syndrome in Children With COVID-19

Frontiers in Pediatrics, 2022
Multisystem inflammatory syndrome in children (MIS-C) is a newly defined hyperinflammatory disease linked to antecedent coronavirus disease 2019. Patients with MIS-C present with various symptoms, and ocular findings such as mild bilateral conjunctivitis
Daisuke Matsubara, Daisuke Tamura, Yuka Kasuya, Yoshitaka Mizobe, Mami Hiwada, Mitsuru Seki, Shinji Makino, Takanori Yamagata   +7 more
doaj   +1 more source

MIS-C and Cardiac Conduction Abnormalities [PDF]

Pediatrics, 2020
OBJECTIVES: Multisystem inflammatory syndrome in children (MIS-C) has spread through the pediatric population during the coronavirus disease 2019 pandemic. Our objective for the study was to report the prevalence of conduction anomalies in MIS-C and identify predictive factors for the conduction abnormalities.
Nak Hyun, Choi, Michael, Fremed, Thomas, Starc, Rachel, Weller, Eva, Cheung, Anne, Ferris, Eric S, Silver, Leonardo, Liberman   +7 more
openaire   +2 more sources

Neonatal MIS-C: Managing the Cytokine Storm [PDF]

Pediatrics, 2021
A term infant girl with uneventful antenatal history had an erythematous rash followed by fever from day 8. She was diagnosed with late-onset sepsis and was treated accordingly. She received immunoglobulin for persistent thrombocytopenia, after which there was transient improvement. The patient was transferred to our hospital on day 25 after recurrence
Sumita, Saha, Priyankar, Pal, Devdeep, Mukherjee   +2 more
openaire   +2 more sources